Aims and Scope
Cancer Cell is a peer-reviewed scientific journal scientific journal that publishes articles that provide major advances in cancer research and oncology. The journal considers manuscripts that answer important questions relevant to naturally occurring cancers. Areas covered include basic cancer biology, therapeutic development, translational research, cancer model development, multi-omics and computational biology. Cancer Cell is also interested in publishing clinical investigations, in particular those that lead to establishing new paradigms in the treatment, diagnosis, or prevention of cancers; those that provide important insights into cancer biology beyond what has been revealed by preclinical studies; and those that are mechanism-based proof-of-principle clinical studies.
Key Metrics
41.9
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
0.05 - 0.1
Eigenfactor
Eigenfactor
Eigenfactor Score measures the number of times articles from the journal published in the past five years have been cited. This does not include self citations.
>= 25
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
378
H index
H-Index
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
0.94
5-Year SI
5-year SI
- 0.89 2-year SI
- 0.92 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q1
Oncology
SJR
- Q1 Oncology
- Q1 Cell Biology
- Q1 Cancer Research
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
5.38
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
9 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Topics Covered
- Cancer
- Myeloid leukemia
- Transcription factor
- Lung cancer
- Tumor microenvironment
- Ependymoma
- Senescence
- Chimeric antigen receptor
- DNA damage
- Crosstalk
- Cerebrospinal fluid
- Breast cancer
- Stanniocalcin
- Gemcitabine
- Cancer gene
- Antitumor activity
- Adrenal medulla
- Down syndrome
- Phagocytosis
- Precision medicine
Journal Specifications
| Overview | |
| Publisher | CELL PRESS |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2002 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Cancer Cell ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Personalized neoantigen vaccine NEO-PV-01 with chemotherapy and anti-PD-1 as first-line treatment for non-squamous non-small cell lung cancer
- 1 Sep 22
- Cancer Cell
-
Full paper
Targeting lineage plasticity overcomes chemoresistance
- 1 Sep 22
- Cancer Cell
-
Full paper
Innate lymphoid cells recruit T cells to turn up the heat on tumors
- 1 Apr 22
- Cancer Cell
-
Full paper
Recognition of observer effect is required for rigor and reproducibility of preclinical animal studies
- 1 Mar 22
- Cancer Cell
-
Full paper
Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer
- 1 Dec 21
- Cancer Cell
-
Full paper
Using epigenetic modifiers to target cancer stem cell immunoevasion
- 1 Dec 21
- Cancer Cell
Scite analysis
Powered by scite_
3.8k articles received 662.8k citations see all
- 29,116 Supporting
- 626,709 Mentioning
- 2,322 Contrasting
Editorial notices
- 6 Retractions
- 0 Withdrawals
- 0 Corrections
- 165 Errata
- 0 Expression of Concern
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
1%
4 to 6 months
11%
7 to 9 months
42%
Above 9 months
45%
Did you find this useful?
Thank you for your feedback.
FAQs
How long has Cancer Cell been actively publishing?
Cancer Cell has been in operation since 2002 till date.
What is the publishing frequency of Cancer Cell ?
Cancer Cell published with a Monthly frequency.
How many articles did Cancer Cell publish last years ?
In 2023, Cancer Cell published articles.
What is the eISSN & pISSN for Cancer Cell ?
For Cancer Cell,eISSN is 1878-3686 and pISSN is1535-6108.
What is Citescore for Cancer Cell ?
Citescore for Cancer Cell is 41.9.
What is H index for Cancer Cell ?
H index for Cancer Cell is 378.
What is SNIP score for Cancer Cell ?
SNIP score for Cancer Cell is 5.38.
What is the SJR for Cancer Cell ?
SJR for Cancer Cell is Q1.
Who is the publisher of Cancer Cell ?
CELL PRESS is the publisher of Cancer Cell.